Abstract
Background: The therapy of symptomatic uterine fibroids is based on three pillars: surgical therapy, conservative medicinal therapy and interventional therapy with high-intensity focused ultrasound (HIFU) and uterine artery embolization (UAE). In recent years, innovative drugs and techniques have been introduced in all of the three therapeutic categories. Ulipristal acetate (UPA), a selective progesterone receptor modulator (SPRM) is now licensed for the preoperative treatment of fibroids. Surgery and minimally invasive surgery: Surgery is still the most efficient option in the treatment of myoma-related symptoms. In the surgical setting, innovations in laparoscopy and hysteroscopy permit uterus-preserving methods. Minimally invasive surgery reduces perioperative risks, enables outpatient surgery and facilitates a rapid recovery. Therefore, minimally invasive surgery is favored even in terms of health economic aspects. For patients with myoma-associated subfertility, surgery is still recommended as the standard therapeutic option.
| Translated title of the contribution | Operative options for uterine fibroids |
|---|---|
| Original language | German |
| Journal | Gynakologische Endokrinologie |
| Volume | 13 |
| Issue number | 4 |
| Pages (from-to) | 219-225 |
| Number of pages | 7 |
| ISSN | 1610-2894 |
| DOIs | |
| Publication status | Published - 01.10.2015 |
